Skip to main content
    D

    Dogwood Therapeutics, Inc. (DWTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.06
    -0.05 (-4.50%)

    Market Cap: $42.43M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    Dogwood Therapeutics, Inc. (DWTX) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Dogwood Therapeutics (DWTX) is expected to report earnings on Mar 16, 2027. In the quarter ended Sep 30, 2026, Dogwood Therapeutics reported EPS of -$0.14, above the -$0.15 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    62%(13/21)
    Avg Surprise
    -19.20%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 16, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.16
    RangeN/A
    4 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts
    Reports May 12, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.16
    Range-$0.16 - -$0.16
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.15-6.7%
    60d ago-$0.160.0%
    30d ago-$0.160.0%
    7d ago-$0.160.0%
    Current-$0.16
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    DWTX has an expected report date of Mar 16, 2027.

    Earnings History

    Of the 21 quarters below that had an estimate, DWTX beat 13, missed 6 and matched 2. The widest gap in the table came in the quarter ended Sep 30, 2025, when EPS landed 418.99% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.14-$0.15-$0.16 - -$0.15+6.67%BeatN/A20 up, 2 downNov 5, 2026
    Jun 30, 2026-$0.34-$0.13-$0.15 - -$0.13-161.54%MissN/A32 up, 0 downAug 13, 2026
    Mar 31, 2026-$0.15-$0.20-$0.30 - -$0.13+25.00%BeatN/A31 up, 0 downMay 14, 2026
    Dec 31, 2025-$0.26-$0.86-$2.00 - -$0.14+69.77%BeatN/A31 up, 0 downMar 18, 2026
    Sep 30, 2025-$8.20-$1.58-$2.30 - -$0.45-418.99%MissN/A31 up, 0 downNov 6, 2025
    Jun 30, 2025-$1.99-$1.90N/A-4.74%MissN/AN/AN/AAug 13, 2025
    Mar 31, 2025-$8.45-$0.76N/AN/AN/AN/AN/A0 up, 0 downMay 8, 2025
    Dec 31, 2024-$6.29-$0.06N/AN/AN/AN/AN/A0 up, 0 downFeb 26, 2025
    Sep 30, 2024-$2.05-$1.18N/A-73.73%MissN/AN/AN/ANov 7, 2024
    Jun 30, 2024-$1.25-$1.58N/A+20.89%BeatN/AN/AN/AAug 8, 2024
    Mar 31, 2024-$1.75-$1.00N/A-75.00%MissN/AN/AN/AMay 9, 2024
    Dec 31, 2023-$0.06-$0.06N/A0.00%In lineN/AN/AN/AFeb 29, 2024
    Sep 30, 2023-$1.50-$2.25N/A+33.33%BeatN/AN/AN/ANov 13, 2023
    Jun 30, 2023-$2.00-$1.25N/A-60.00%MissN/AN/AN/AAug 10, 2023
    Mar 31, 2023-$0.08-$0.16N/A+50.00%BeatN/AN/AN/AMay 11, 2023
    Dec 31, 2022-$2.75-$3.75N/A+26.67%BeatN/AN/AN/AMar 31, 2023
    Sep 30, 2022-$7.00-$11.50N/A+39.13%BeatN/AN/AN/ANov 14, 2022
    Jun 30, 2022-$11.00-$12.25N/A+10.20%BeatN/AN/AN/AAug 11, 2022
    Mar 31, 2022-$12.00-$13.75N/A+12.73%BeatN/AN/AN/AMay 12, 2022
    Dec 31, 2021-$0.54-$0.54N/A0.00%In lineN/AN/AN/AMar 31, 2022
    Sep 30, 2021-$12.25-$17.25N/A+28.99%BeatN/AN/AN/ANov 11, 2021
    Jun 30, 2021-$12.75-$13.75N/A+7.27%BeatN/AN/AN/AAug 12, 2021
    Mar 31, 2021-$9.25-$23.25N/A+60.22%BeatN/AN/AN/AMay 13, 2021
    Dec 31, 2020-$1.25N/AN/AN/AN/AN/AN/AN/AMar 31, 2021
    Sep 30, 2020-$0.35N/AN/AN/AN/AN/AN/AN/ADec 18, 2020
    Jun 30, 2020-$0.08N/AN/AN/AN/AN/AN/AN/AAug 28, 2020
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$18.90, after -$11.34 the year before. It was -$1.68 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$18.90N/A
    Dec 31, 2024-$11.34N/A
    Dec 31, 2023-$3.64N/A
    Dec 31, 2022-$32.75N/A
    Dec 31, 2021-$34.79N/A
    Dec 31, 2020-$1.68N/A

    Frequently Asked Questions About DWTX

    When is Dogwood Therapeutics's next earnings date?

    Dogwood Therapeutics's next earnings report is expected for Mar 16, 2027.

    Did DWTX beat earnings estimates last quarter?

    Yes. Dogwood Therapeutics reported EPS of -$0.14 for the quarter ended Sep 30, 2026, above the -$0.15 estimate, a 6.67% surprise.

    What EPS do analysts expect from DWTX next quarter?

    The consensus EPS estimate for Dogwood Therapeutics for the quarter ending Dec 31, 2026 is -$0.16 from 4 analysts.

    How often does DWTX beat earnings estimates?

    Dogwood Therapeutics beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of -67.08%.